Movatterモバイル変換

[0]ホーム
URL:

MA43291A1 - Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their use - Google Patents

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their use

Info

Publication number
MA43291A1
MA43291A1MA43291AMA43291AMA43291A1MA 43291 A1MA43291 A1MA 43291A1MA 43291 AMA43291 AMA 43291AMA 43291 AMA43291 AMA 43291AMA 43291 A1MA43291 A1MA 43291A1
Authority
MA
Morocco
Prior art keywords
combinations
positive allosteric
glutamatergic receptor
receptor subtype
allosteric modulators
Prior art date
Application number
MA43291A
Other languages
French (fr)
Other versions
MA43291B1 (en
Inventor
Brian D Klein
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority claimed from PCT/EP2015/051029external-prioritypatent/WO2015110435A1/en
Publication of MA43291A1publicationCriticalpatent/MA43291A1/en
Publication of MA43291B1publicationCriticalpatent/MA43291B1/en

Links

Classifications

Landscapes

Abstract

Translated fromFrench

La présente invention concerne des combinaisons comprenant un modulateur allostérique positif (« pam ») de sous-type 2 de récepteur glutamatergique métabotrope (« mglur2 ») ou un sel ou solvate pharmaceutiquement acceptable de ce dernier, ou un agoniste orthostérique de composé de sous-type 2 de récepteur glutamatergique métabotrope ou un sel ou solvate pharmaceutiquement acceptable de ce dernier, et un ligand de protéine 2a de vésicule synaptique (« sv2a »).The present invention relates to combinations comprising a methotrotropic glutamatergic receptor subtype 2 ("mglur2") positive allosteric modulator ("pam"), or a pharmaceutically acceptable salt or solvate thereof, or an orthosteric subtype compound agonist. type 2 metabotropic glutamatergic receptor or a pharmaceutically acceptable salt or solvate thereof, and a synaptic vesicle protein 2a ligand ("sv2a").

MA43291A2014-02-042015-01-20 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their useMA43291B1 (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
EP141538802014-02-04
PCT/EP2015/051029WO2015110435A1 (en)2014-01-212015-01-20Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Publications (2)

Publication NumberPublication Date
MA43291A1true MA43291A1 (en)2018-11-30
MA43291B1 MA43291B1 (en)2019-05-31

Family

ID=50030211

Family Applications (3)

Application NumberTitlePriority DateFiling Date
MA39209AMA39209A1 (en)2014-02-042015-01-20 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their use
MA43290AMA43290B1 (en)2014-02-042015-01-20 Combinations comprising positive allosteric modulators or orthosteric agonists of subtype 2 metabotropic glutamatergic receptor, and their use
MA43291AMA43291B1 (en)2014-02-042015-01-20 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their use

Family Applications Before (2)

Application NumberTitlePriority DateFiling Date
MA39209AMA39209A1 (en)2014-02-042015-01-20 Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their use
MA43290AMA43290B1 (en)2014-02-042015-01-20 Combinations comprising positive allosteric modulators or orthosteric agonists of subtype 2 metabotropic glutamatergic receptor, and their use

Country Status (1)

CountryLink
MA (3)MA39209A1 (en)

Also Published As

Publication numberPublication date
MA43291B1 (en)2019-05-31
MA39209A1 (en)2017-10-31
MA43290A1 (en)2018-11-30
MA43290B1 (en)2019-05-31

Similar Documents

PublicationPublication DateTitle
EP4069686A4 (en) GPP-1 RECEPTOR AGONISTS
EP3923933A4 (en) PYRROLIDINOREXINE RECEPTOR AGONISTS
DK3762380T3 (en) PHENYLPYRROLIDINONE FORMYLPEPTIDE-2 RECEPTOR AGONISTS
EP3755311A4 (en) INDANAMINE AS PD-L1 ANTAGONISTS
MA41481B1 (en) Dosage regimen for ponesimod, a selective s1p1 receptor agonist
CY1124207T1 (en) COMBINATIONS COMPRISING POSITIVE ALLOSTERIC REGULATORS OF GLUTAMINERGIC RECEPTOR SUBTYPE 2 AND USES THEREOF
EA201790373A1 (en) METHODS OF OBTAINING MODULATORS OF TOLL-SIMILAR RECEPTORS
PH12019500128A1 (en)Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
MA39209A1 (en) Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2, and their use
EA201991895A3 (en) COMBINATIONS CONTAINING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR 2 SUBTYPE, AND THEIR APPLICATION
HK40039646A (en)Synthetic rig-i-like receptor agonists
[8]ページ先頭
©2009-2025 Movatter.jp